Monday, May 20, 2019
Time | Event | |
07:00 - 08:00 | Paper free - Ecoresponsible congress - QR code will be available to get online access to the programm - QR code will be avalable to get one line access to the programm | |
08:00 - 09:00 | Registration, Coffee | |
09:00 - 09:30 | Welcome speach - Welcome speach | |
09:30 - 10:00 | Tuning the ribosome in health and cancer - Anders Lund | |
10:00 - 10:30 | Eukaryotic Ribosomal RNA Modification - Denis Lafontaine | |
10:30 - 11:00 | Coffee break | |
11:00 - 11:30 | Cap methyltransferase and c-Myc and ribosomal protein production - Victoria Cowling | |
11:30 - 12:00 | Global and transcript-specific analysis of translational control in disease - the eIF3 perspective - Leos Valasek | |
12:00 - 12:30 | Modelling ribosome dynamic in cancer cell - Jean-Charles Walter | |
12:30 - 14:00 | Lunch | |
14:00 - 14:30 | Lecture from Pr Norbert Ifrah, President of National Cancer Institute (INCa) - Pr Norbert Ifrah | |
14:30 - 15:00 | The role of eIF4B in dysregulation of mRNA translation in DLBCL - Anne Willis | |
15:00 - 15:30 | Translational control of pancreatic carcinogenesis - Yvan Martineau | |
15:30 - 16:00 | Ribosome alterations in cancer : impact on translational control and tumorigenesis - Jean-Jacques Diaz | |
16:00 - 16:30 | Coffee break | |
16:30 - 17:00 | synthetic small molecules RNA ligands: scope and applications in cancer chemotherapy - Maria Duca | |
17:00 - 17:30 | Translational control of the stroma in cancer initiation and progression - Ola Larsson | |
17:30 - 17:50 | Estrogen receptor alpha controls gene expression via translational offsetting - Julie Lorent | |
17:50 - 18:10 | Targeting protein synthesis reshapes metabolism of malignant mesothelioma primary cells - Stefano Grosso | |
18:10 - 18:30 | Novel use of 5-Fluorouracil as readthrough inducer: Rescuing nonsense mutant TP53 in human tumor cells - Mireia Palomar-Siles | |
18:30 - 18:50 | Profiling cisplatin induced rearrangement of RNA-binding proteins on the CDKN1B/p27 3’UTR identifies modulators of drug sensitivity - André Gerber | |
18:50 - 19:10 | Identifying RNA binding proteins relevant for melanoma progression - Neus Mestre Farràs | |
19:10 - 20:00 | Drinks and Poster Session 1 - Drinks and Poster Session 1 |
Tuesday, May 21, 2019
Time | Event | |
07:00 - 08:00 | Running session in Montpellier - Running session in Montpellier | |
08:30 - 09:00 | Coffee break | |
09:00 - 09:30 | Codon-specific mRNA translation reprogramming in cancer - Pierre Close | |
09:30 - 10:00 | 2'-O-Me in human rRNA and ribosome heterogeneity - Henrik Nielsen | |
10:00 - 10:30 | RNA modification and stem cell homeostasis - Michaela Frye | |
10:30 - 11:00 | Coffee break | |
11:00 - 11:30 | RNA methylation shapes cancer cell fate - Alexandre David | |
11:30 - 12:00 | to be announced - Martin Bushell | |
12:00 - 12:30 | A translatome view of p53-dependent apoptosis - Alberto Inga | |
12:30 - 14:00 | Lunch | |
14:00 - 14:30 | Translational control of the tumor stress response confers metastatic capacity - Poul Sorensen | |
14:30 - 15:00 | Cellular Responses to Chronic Stress - Maria Hatzoglou | |
15:00 - 15:30 | Cap independent translation and cancer - Romao Luisa | |
15:30 - 16:00 | Lighting up stress induced changes in translation - David Tollervey | |
16:00 - 17:00 | Coffee break and Poster Session | |
17:00 - 17:30 | poly(A) RNA turnover and oncogenic transformation - Georg Stoecklin | |
17:30 - 17:50 | Sponsor presentation: Qiagen - Hélène Bauby | |
17:50 - 18:10 | Sponsor presentation: PPC - Christophe Hirtz | |
18:10 - 18:30 | Towards the understanding of a dynamic 2’-O-methylation in the 18S rRNA - Kasper Andersen | |
18:30 - 18:50 | HnRNP H/F drive RNA G-quadruplex-mediated translation linked to genomic instability and therapy resistance in glioblastoma - Pauline Herviou | |
18:50 - 19:10 | Translation initiation factor INT6/eIF3e is a target for human glioma cell radio-sensitization through regulation of specific mRNA translation - Juliette Bertorello | |
19:30 - 23:55 | Gala Dinner |
Wednesday, May 22, 2019
Time | Event | |
08:30 - 09:00 | Coffee break | |
09:00 - 09:30 | Linking leukaemia with defective ribosome assembly - Alan Warren | |
09:30 - 10:00 | UNR/CSDE1 in cancer progression and suppression - Fatima Gebauer | |
10:00 - 10:30 | LARP1 as a therapeutic target in ovarian cancer - Sarah Blagden | |
10:30 - 11:00 | Coffee break | |
11:00 - 11:30 | CPEB1/CPEB4 balance controls skin homeostasis and squamous Cell Carcinoma development - Raul Mendez | |
11:30 - 12:00 | Targeting translation in colorectal cancer - Owen Sansom | |
12:00 - 12:30 | Conclusion, highlights and outcomes - Conclusion | |
12:30 - 14:00 | Lunch | |
12:30 - 14:00 | OFF SESSION lunch with PIs (European Network) - OFF SESSION lunch with PIs (European Network) | |
14:00 - 16:00 | OPEN SESSION with stakeholders (patient associations, industrials, clinicians) - OFF SESSION with stakeholders (patient associations, industrials, cliniciustrials, clinicians) |